Universita' Degli Studi Di Verona
- Address
- lock Available on a paid plan
Neoplasms and Urologic Oncology
At the Universita' Degli Studi Di Verona, research in neoplasms focuses on cancers such as high-risk localized or locally advanced prostate cancer and acute lymphoblastic leukemia. These studies are designed to assess whether new treatment approaches can improve cancer control and long-term outcomes.
- Evaluating treatment effectiveness in prostate cancer
- Improving survival outcomes in infant acute lymphoblastic leukemia
- Supporting better cancer care through new therapeutic strategies
This work reflects a strong clinical focus on testing therapies that may offer more effective options for patients with difficult-to-treat cancers.
Cardiovascular Diseases and Stroke Prevention
Clinical trials in cardiovascular diseases at this site are centered on reducing the risk of ischemic stroke after a recent event such as an acute stroke or high-risk transient ischemic attack. The main goal is to determine whether new antithrombotic treatments can better prevent future strokes while maintaining safety.
- Preventing recurrent ischemic stroke
- Studying treatment options after transient ischemic attack
- Balancing effectiveness with bleeding risk
These studies aim to improve secondary prevention for people at elevated risk of another cerebrovascular event.
Eye Diseases and Pediatric Ophthalmic Care
Research in eye diseases includes studies involving children and adolescents who need ocular surface anesthesia for eye examinations. The purpose is to compare approaches that may make routine ophthalmic care more comfortable and effective for young patients.
- Improving ocular anesthesia for pediatric eye exams
- Supporting comfort during ophthalmic procedures
- Evaluating practical options for everyday clinical use
This area highlights a patient-friendly focus on making pediatric eye care easier while maintaining clinical effectiveness.
Nutritional and Metabolic Diseases and Weight Management
Trials in nutritional and metabolic diseases at the Verona site address obesity and overweight in adolescents with related health conditions. The research is aimed at assessing whether new therapies can help improve weight control and associated health outcomes.
- Managing obesity in adolescents
- Addressing overweight with weight-related comorbidities
- Testing treatments that may support healthier metabolic outcomes
These studies are part of a broader effort to find better options for young people affected by excess weight and its complications.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 28 therapeutic areas and 15 of 368 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 347 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 83 by active trials.
lock +82 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG10trials
lock +45 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Universita' Degli Studi Di Verona
lock Showing 1 of 231 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (Peak) A Phase 3 Randomized, Open-label, Multicenter Clinical Study of CGT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors | Cogent Biosciences Inc. | Phase III | Not Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 368 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cisplatin | 25 | Unknown | 2015-06-02 | 2026-02-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.